Novel nanoparticle-based COVID vaccines induce long-term neutralizing antibody response
| Date | 22nd, Mar 2022 |
|---|---|
| Source | News Medical - Scientific News Websites |
DESCRIPTION
Researchers report the results for a new SARS-CoV-2 vaccine currently in Phase III clinical trial known as I53-50.